154 related articles for article (PubMed ID: 26105511)
1. Novel chemiluminescent imaging microtiter plates for high-throughput detection of multiple serum biomarkers related to Down's syndrome via soybean peroxidase as label enzyme.
Zhao F; Chai D; Lu J; Yu J; Liu S
Anal Bioanal Chem; 2015 Aug; 407(20):6117-26. PubMed ID: 26105511
[TBL] [Abstract][Full Text] [Related]
2. A portable chemiluminescence imaging immunoassay for simultaneous detection of different isoforms of prostate specific antigen in serum.
Liu A; Zhao F; Zhao Y; Shangguan L; Liu S
Biosens Bioelectron; 2016 Jul; 81():97-102. PubMed ID: 26922048
[TBL] [Abstract][Full Text] [Related]
3. Combining inhibin A with existing second-trimester markers in maternal serum screening for Down's syndrome.
Cuckle HS; Holding S; Jones R; Groome NP; Wallace EM
Prenat Diagn; 1996 Dec; 16(12):1095-100. PubMed ID: 8994244
[TBL] [Abstract][Full Text] [Related]
4. [AFP, uE3, beta-hCG levels applied for prenatal diagnosis of Down's syndrome].
Liao S; Wang Y; Ye G
Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):655-8. PubMed ID: 9639764
[TBL] [Abstract][Full Text] [Related]
5. Serum markers for Down's syndrome in relation to number of previous births and maternal age.
Wald NJ; Watt HC
Prenat Diagn; 1996 Aug; 16(8):699-703. PubMed ID: 8878278
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of Down's syndrome screening methods using maternal serum biochemistry in the second trimester pregnancy].
Yu DY; Fu P; Zhang ZH; Wang F; Han MY; Ren HY; Zhao W; Zhang K; Li S; Jiang N
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Jun; 28(3):332-5. PubMed ID: 21644235
[TBL] [Abstract][Full Text] [Related]
7. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
[TBL] [Abstract][Full Text] [Related]
8. Prenatal screening for Down's syndrome using inhibin-A as a serum marker.
Wald NJ; Densem JW; George L; Muttukrishna S; Knight PG
Prenat Diagn; 1996 Feb; 16(2):143-53. PubMed ID: 8650125
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age.
Hsu JJ; Hsieh TT; Soong YK; Spencer K
Prenat Diagn; 1997 Aug; 17(8):707-16. PubMed ID: 9267893
[TBL] [Abstract][Full Text] [Related]
10. Second trimester maternal dimeric inhibin-A in the multiple-marker screening test for Down's syndrome.
Renier MA; Vereecken A; Van Herck E; Straetmans D; Ramaekers P; Buytaert P
Hum Reprod; 1998 Mar; 13(3):744-8. PubMed ID: 9572446
[TBL] [Abstract][Full Text] [Related]
11. First-trimester or second-trimester screening, or both, for Down's syndrome.
Malone FD; Canick JA; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Berkowitz RL; Gross SJ; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Dukes K; Bianchi DW; Rudnicka AR; Hackshaw AK; Lambert-Messerlian G; Wald NJ; D'Alton ME;
N Engl J Med; 2005 Nov; 353(19):2001-11. PubMed ID: 16282175
[TBL] [Abstract][Full Text] [Related]
12. Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital.
Lamlertkittikul S; Chandeying V
J Med Assoc Thai; 2007 Oct; 90(10):1970-6. PubMed ID: 18041410
[TBL] [Abstract][Full Text] [Related]
13. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
[TBL] [Abstract][Full Text] [Related]
14. Cross-trimester repeated measures testing for Down's syndrome screening: an assessment.
Wright D; Bradbury I; Malone F; D'Alton M; Summers A; Huang T; Ball S; Baker A; Nix B; Aitken D; Crossley J; Cuckle H; Spencer K
Health Technol Assess; 2010 Jul; 14(33):1-80. PubMed ID: 20624355
[TBL] [Abstract][Full Text] [Related]
15. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays.
Spencer K
Ann Clin Biochem; 2005 Jan; 42(Pt 1):30-40. PubMed ID: 15802030
[TBL] [Abstract][Full Text] [Related]
16. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A.
Wallace EM; Swanston IA; McNeilly AS; Ashby JP; Blundell G; Calder AA; Groome NP
Clin Endocrinol (Oxf); 1996 Jan; 44(1):17-21. PubMed ID: 8706288
[TBL] [Abstract][Full Text] [Related]
17. Down's syndrome risk estimates demonstrate considerable heterogeneity despite homogeneity of input.
Reynolds T; Ellis A; Jones R
Ann Clin Biochem; 2004 Nov; 41(Pt 6):464-8. PubMed ID: 15588435
[TBL] [Abstract][Full Text] [Related]
18. Dual analyte immunoassay in neural tube defect and Down's syndrome screening: results of a multicentre clinical trial.
Spencer K; Macri JN; Anderson RW; Aitken DA; Berry E; Crossley JA; Wood PJ; Coombes EJ; Stroud M; Worthington DJ
Ann Clin Biochem; 1993 Jul; 30 ( Pt 4)():394-401. PubMed ID: 7691041
[TBL] [Abstract][Full Text] [Related]
19. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
Benn PA
Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
[TBL] [Abstract][Full Text] [Related]
20. Effect of gravidity on maternal serum markers for Down's syndrome.
Barkai G; Goldman B; Ries L; Chaki R; Cuckle H
Prenat Diagn; 1996 Apr; 16(4):319-22. PubMed ID: 8734805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]